QSAM Biosciences Announces Submission of IND Application for CycloSam® with FDA
Austin, TX, May 04, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: [...]
QSAM Biosciences Appoints Richard K. Burt, M.D., Pioneer in the Use of Stem Cell Transplants to Treat Autoimmune Diseases, to Scientific Board of Advisors
Austin, TX, April 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: [...]
QSAM Biosciences Issues Letter from CEO on Successful Achievements and Future Milestones for Company
Austin, TX, April 19, 2021 (GLOBE NEWSWIRE) -- The Chief [...]
QSAM Biosciences Seeks to Expand Radiochemical Assets; Signs Option Agreement to License its Second Promising Cancer Therapy
Austin, Texas, March 17, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences, [...]
QSAM Biosciences Appoints Charles J. Link, Jr., M.D., Experienced Biotech Executive and Innovator, to Board of Directors
Austin, TX, Feb. 16, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: [...]
QSAM Biosciences Closes Series B Preferred Private Placement; $2.5 Million in New Capital to Fund Upcoming Clinical Trials
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: [...]
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences [...]
QSAM Biosciences Receives Notice of Allowance for European Patent and Expands Licensed IP Portfolio
Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences [...]
QSAM Biosciences Issues Letter from New CEO; Presents Opportunities Ahead for Company
Palm Beach, FL, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The [...]
QSAM Biosciences Advances Plan of Separation from Legacy Business
Palm Beach, FL, November 10, 2020 – QSAM Biosciences Inc. [...]